Join us as Seth Clark, MD & Juliette Holtzman, MSW from LifeSpan Addiction Medicine team share their approach to supporting individuals living with Opioid Use Disorder. Upon attending this session, participants will be able to: 1. Identify key considerations to support uptake of patient-centered and evidence-based care. 2. Explore promising practices for delivering treatment for […]
IPRO and the Opioid Response Network (ORN) have developed an education series for use by nursing home staff educators. Our goal is to provide a resource to nursing homes/medical rehabilitation centers that supports your commitment to ensure all residents/patients receive equitable care. This education series will address the often missed, yet impactful issues of addiction, […]
WHAT IS AN AFFINITY GROUP? Affinity Groups highlight best practices, resources, and successful solutions to challenges. Opioid Stewardship Affinity Group attendees will: Discuss how to initiate/expand a hospital Opioid Stewardship program. Share best practices, resources, and successful solutions to challenges. Pose questions to subject matter experts (SMEs) who have implemented successful programs. Evaluate data and […]
More than 1 million Medicare beneficiaries had a diagnosis of opioid use disorder (OUD) in 2020. However, fewer than one in five received medication to treat this condition. In addition, the number of patients who stay in treatment after hospital discharge decrease drastically. This webinar series is a collaboration between all Quality Innovation Network-Quality Improvement […]
More than 1 million Medicare beneficiaries had a diagnosis of opioid use disorder (OUD) in 2020. However, fewer than one in five received medication to treat this condition. In addition, […]
Learning Objectives At the completion of this activity learners will be able to: Describe how to effectively recognize and respond to an opioid-involved breathing emergency, including considerations with xylazine and illicitly manufactured fentanyl. Counsel patients and caregivers on how to use unregulated substances more safely and where to find recovery resources. Dispel myths and provide […]
More than 1 million Medicare beneficiaries had a diagnosis of opioid use disorder (OUD) in 2020. However, fewer than one in five received medication to treat this condition. In addition, the number of patients who stay in treatment after hospital discharge decrease drastically. This webinar series is a collaboration between all Quality Innovation Network-Quality Improvement […]
More than 1 million Medicare beneficiaries had a diagnosis of opioid use disorder (OUD) in 2020. However, fewer than one in five received medication to treat this condition. In addition, the number of patients who stay in treatment after hospital discharge decrease drastically. This webinar series is a collaboration between all Quality Innovation Network-Quality Improvement […]
More than 1 million Medicare beneficiaries had a diagnosis of opioid use disorder (OUD) in 2020. However, fewer than one in five received medication to treat this condition. In addition, […]
More than 1 million Medicare beneficiaries had a diagnosis of opioid use disorder (OUD) in 2020. However, fewer than one in five received medication to treat this condition. In addition, […]
More than 1 million Medicare beneficiaries had a diagnosis of opioid use disorder (OUD) in 2020. However, fewer than one in five received medication to treat this condition. In addition, the number of patients who stay in treatment after hospital discharge decrease drastically. This webinar series is a collaboration between all Quality Innovation Network-Quality Improvement […]
More than 1 million Medicare beneficiaries had a diagnosis of opioid use disorder (OUD) in 2020. However, fewer than one in five received medication to treat this condition. In addition, […]